Uterine Cancer-Pipeline Insights, 2016


#516315

60pages

DelveInsight

$ 1250

In Stock

SUMMARY
DelveInsights, Uterine Cancer-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Uterine Cancer. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Uterine Cancer. DelveInsights Report also assesses the Uterine Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope

Table of Contents
Uterine Cancer Overview
Uterine Cancer Pipeline Therapeutics
Uterine Cancer Therapeutics under Development by Companies
Uterine Cancer Filed and Phase III Products
Comparative Analysis
Uterine Cancer Phase II Products
Comparative Analysis
Uterine Cancer Phase I and IND Filed Products
Comparative Analysis
Uterine Cancer Discovery and Pre-Clinical Stage Products
Comparative Analysis
Drug Candidate Profiles
Uterine Cancer Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Uterine Cancer Discontinued Products
Uterine Cancer Dormant Products
Companies Involved in Therapeutics Development for Uterine Cancer
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Uterine Cancer, 2016
Number of Products under Development by Companies
Comparative Analysis by Filed and Phase III Products, 2016
Comparative Analysis Phase II Products, 2016
Comparative Analysis Phase I and IND Filed Products, 2016
Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
Drug Candidates Profiles
Uterine Cancer Assessment by Monotherapy Products
Uterine Cancer Assessment by Combination Products
Uterine Cancer Assessment by Route of Administration
Uterine Cancer Assessment by Stage and Route of Administration
Uterine Cancer Assessment by Molecule Type
Uterine Cancer Assessment by Stage and Molecule Type
Uterine Cancer Therapeutics Discontinued Products
Uterine Cancer Therapeutics Dormant Products
Products under Development by Companies, 2016

List of Figures
Number of Products under Development for Uterine Cancer, 2016
Filed and Phase III Products, 2016
Phase II Products, 2016
Phase I and IND Filed Products, 2016
Discovery and Pre-Clinical Stage Products, 2016
Uterine Cancer Assessment by Monotherapy Products
Uterine Cancer Assessment by Combination Products
Uterine Cancer Assessment by Route of Administration
Uterine Cancer Assessment by Stage and Route of Administration
Uterine Cancer Assessment by Molecule Type
Uterine Cancer Assessment by Stage and Molecule Type